• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Commentary

We could tackle COVID under an effective leader. Trump is not that leader

By
Sten H. Vermund
Sten H. Vermund
,
Ahmed Mushfiq Mobarak
Ahmed Mushfiq Mobarak
and
Howard P. Forman
Howard P. Forman
Down Arrow Button Icon
By
Sten H. Vermund
Sten H. Vermund
,
Ahmed Mushfiq Mobarak
Ahmed Mushfiq Mobarak
and
Howard P. Forman
Howard P. Forman
Down Arrow Button Icon
November 2, 2020, 12:50 PM ET
Under President Trump, write the authors, “recommendations from public health experts—based on classic, tried-and-tested strategies—have fallen on deaf ears at the White House.”
Under President Trump, write the authors, “recommendations from public health experts—based on classic, tried-and-tested strategies—have fallen on deaf ears at the White House.”Biden: Chip Somodevilla—Getty Images; Trump: Mark Makela—Getty Image

A recent Wall Street Journal editorial accuses Vice President Biden of weaving a fairy tale about COVID-19 and contrasts this with President Trump’s “sensible” response to the pandemic. The editorial argues that Biden simply wants voters to trust him, without his having presented a coherent plan that would be any different from the current President’s.

It is true that in a democracy, we don’t normally put faith in the ability of any single individual to solve complex social challenges, let alone deliver us salvation from a once-in-a-lifetime crisis like the one we have been in the midst of for months. However, the current administration’s approach has been such a massive failure, with a reluctance to undertake even the most basic, cost-effective defensive actions that were well within our nation’s financial and technological capabilities, that there is reason to be hopeful about our prospects under any future functional administration.     

Biden’s science-based strategic plan commits to simple, effective steps like mask wearing, physical distancing, hand and surface hygiene, restricting indoor gatherings to small groups in spaces with excellent air quality, scaling up testing and contact tracing, and restoring the nation’s faith in scientific expertise and confidence in our public health infrastructure. Importantly, Biden leads by example and is clear and consistent in his messaging. These are the leadership attributes we now desperately need to undo the damage to evidence-based decision-making wrought by our current President. With new leadership, there will be no more ridiculing simple, sensible public health responses that prevent many thousands of unnecessary deaths in our nation.

Leadership is key to control of any crisis. As many other countries around the world have shown, a more effective response to the pandemic requires sensible, decisive, and empathetic leaders who inspire all citizens to make small sacrifices to protect each other in the interest of our collective well-being. President Macky Sall of Senegal self-quarantined because he was exposed, even after testing negative for SARS-CoV-2. Contrast this with the behavior of U.S. government leaders who continue to ignore basic social distancing and mask guidelines set by their own CDC. Many sub-Saharan African countries that the President has derided in the past began planning their COVID response as soon as the virus alerts were sent internationally and began screening and quarantining travelers at their airports. The comparative indecisiveness and slowness of the U.S. response, in contrast, is likely to cost many thousands of lives. Rwandans are now allowed to travel to Europe, while Americans remain prohibited. The Foreign Policy global COVID-19 response index ranks New Zealand, Japan, Kenya, Australia, and Ghana as the best responders, simply because their leaders followed scientists’ recommendations, and communicated clearly with their citizens to encourage positive behavior change. The U.S. ranks among the bottom five.

Recommendations from public health experts—based on classic, tried-and-tested strategies—have fallen on deaf ears at the White House since the beginning of this pandemic. In February, President Trump’s team failed to deliver necessary quality testing, to rationally coordinate distribution of personal protective equipment, to highlight key hygiene messages, or to educate the public about the threat of the novel coronavirus. For every statement from Drs. Birx and Fauci, there was a counterstatement undermining their guidance. 

In March and April, the need for mask use and physical distancing were given lip service in the White House even as the President and his top aides modeled bad behavior, ignoring recommendations from the public health community. While hawking ineffective medicines and dangerous fringe “therapies” (remember bleach injections and internal light therapy?) and failing to take even basic respiratory transmission precautions within the White House or at mass political rallies, our President ridiculed those who are more responsible than he. 

Global progress toward safe and effective vaccines to prevent infection and better therapies to save lives and lessen hospitalizations will allow us to resume our normal lives and more fully restore our economy, perhaps by late 2021. Yet our President has consistently undermined regulatory authorities and ridiculed scientists; and, not coincidentally, vaccine hesitancy in the general public is now at a record high, according to the Pew Research Center.

The best bet for restoring our nation’s health and economy is to restore the primacy of science and evidence in battling the COVID-19 pandemic. In doing so, we will also begin to reverse White House mistakes ranging from deregulation of environmental and health protections for the public, failing to confront global climate threats, passivity in the face of falling health insurance coverage rates, and inadequate investments to blunt the pandemic economic crisis. Qualified public health experts will no longer be removed to fill slots with political appointees from regulated industries. Classic public health measures can tide us over until the arrival of effective vaccines and superior therapies, but they must be promulgated and respected.

Sten H. Vermund is the dean of the Yale School of Public Health. Ahmed Mushfiq Mobarak is professor of economics at Yale University and founder of the Yale Research Initiative on Innovation and Scale (Y-RISE). Howard Forman is professor at the Yale School of Medicine and director of the Health Care Management program at the Yale School of Public Health, and has advised the Biden campaign.

About the Authors
By Sten H. Vermund
See full bioRight Arrow Button Icon
By Ahmed Mushfiq Mobarak
See full bioRight Arrow Button Icon
By Howard P. Forman
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

Latest in Commentary

Jamie Dimon
CommentaryCorporate Governance
Jamie Dimon’s bombshell on proxy advisory delivers a body blow to the firms he called ‘incompetent’
By Richard TorrenzanoJanuary 7, 2026
19 hours ago
fraser
CommentaryLeadership
The 7 most overlooked CEOs in 2025—and the 5 to watch in 2026
By Jeffrey Sonnenfeld and Stephen HenriquesJanuary 7, 2026
23 hours ago
christian klein
CommentarySoftware
The most honest prediction for 2026: nobody knows what’s next
By Christian KleinJanuary 7, 2026
1 day ago
CES
CommentaryRobots
Beyond the CES hype: why home robots need the self-driving car playbook
By Jason CorsoJanuary 6, 2026
2 days ago
AsiaTariffs and trade
Countries must move beyond seeing AI as a race, where one side must beat the other
By Boris Babic and Brian WongJanuary 3, 2026
5 days ago
trump
CommentaryVenezuela
5 takeaways on Venezuela in the aftermath of Maduro: A memo to CEOs
By Jeffrey SonnenfeldJanuary 3, 2026
5 days ago

Most Popular

placeholder alt text
Law
Amazon is cutting checks to millions of customers as part of a $2.5 billion FTC settlement. Here's who qualifies and how to get paid
By Sydney LakeJanuary 6, 2026
2 days ago
placeholder alt text
Economy
Mark Cuban on the $38 trillion national debt and the absurdity of U.S. healthcare: we wouldn't pay for potato chips like this
By Nick LichtenbergJanuary 6, 2026
2 days ago
placeholder alt text
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top colleges
By Jake AngeloJanuary 6, 2026
2 days ago
placeholder alt text
Personal Finance
Janet Yellen warns the $38 trillion national debt is testing a red line economists have feared for decades
By Eva RoytburgJanuary 5, 2026
3 days ago
placeholder alt text
Personal Finance
Current price of silver as of Tuesday, January 6, 2026
By Joseph HostetlerJanuary 6, 2026
2 days ago
placeholder alt text
Success
MacKenzie Scott sends millions to nonprofit that supports anti-Israel and pro-Muslim groups, two of which are facing federal probes
By Sydney LakeJanuary 6, 2026
2 days ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.